Best Practice Alert to Promote Screening for Primary Aldosteronism Among People With Apparent Treatment-Resistant Hypertension
Authors' conclusion
Implementation of a real-time electronic health record BPA doubled the screening rate for PA among people with aTRH; however, the overall screening rate was low.
Study context
- Population
- People with apparent treatment-resistant hypertension (aTRH) attending office visits at ambulatory primary care, endocrinology, nephrology and cardiology clinics
- Participants
- 11,463 vs 10,944
- Comparison
- Post-BPA vs pre-BPA implementation
- Post-BPAn = 11,463
- Pre-BPAn = 10,944reference
- Outcome
- PA screening rates
- Follow-up
- 12 months before vs after BPA implementation
Methodological detailsquality improvement, noninterruptive electronic health record Best Practice Alert, ambulatory primary care, endocrinology, nephrology and cardiology clinics
- Quality improvement
- Noninterruptive electronic health record Best Practice Alert
- Ambulatory primary care, endocrinology, nephrology and cardiology clinics
Main finding
As reported in the abstract
PA screening orders placed
- Significant increase in primary aldosteronism (PA) screening orders placed after Best Practice Alert (BPA) implementation
- Post-BPA vs Pre-BPA: P < 0.001
Further findings
Positive PA screening tests
P = 0.447
- PA screening labs performed · 12 months before vs after BPA implementation · significant increase after BPA implementation
- P < 0.001
PA screening labs performed · 12 months before vs after BPA implementation
- Significant increase in PA screening labs performed after BPA implementation
Original publication
Best Practice Alert to Promote Screening for Primary Aldosteronism Among People With Apparent Treatment-Resistant Hypertension. Endocr Pract. Published 26 April 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →